MetLife, Inc.
MET · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.84 | -0.95 | -0.52 | -6.80 |
| FCF Yield | 0.00% | 4.05% | 7.78% | 9.00% |
| EV / EBITDA | 36.97 | 38.05 | 30.11 | 33.93 |
| Quality | ||||
| ROIC | 292.07% | 0.22% | 0.29% | 0.28% |
| Gross Margin | 0.00% | 26.43% | 25.85% | 26.38% |
| Cash Conversion Ratio | – | 3.00 | 4.51 | 4.04 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.30% | 0.73% | 1.43% | 0.31% |
| Free Cash Flow Growth | 0.00% | -48.69% | -16.90% | 23.03% |
| Safety | ||||
| Net Debt / EBITDA | -0.00 | -5.14 | -3.88 | -0.83 |
| Interest Coverage | 5.46 | 3.64 | 5.25 | 5.33 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 171.44 | 159.06 | 150.18 |